Company Filing History:
Years Active: 2007-2019
Title: Laura-Leena Kiiskinen: Innovator in Genetic Sequencing
Introduction
Laura-Leena Kiiskinen is a prominent inventor based in Espoo, Finland. With a remarkable portfolio of five patents, she has made significant contributions to the field of genetic sequencing. Her work focuses on advancements in transposon nucleic acids, enhancing the efficiency of DNA library generation.
Latest Patents
Among her latest inventions are two innovative patents related to transposon nucleic acids. The first patent describes "Transposon nucleic acids comprising a calibration sequence for DNA sequencing." This invention outlines a method for creating a DNA fragmentation library utilizing a transposition reaction that incorporates a transposon end with a calibration sequence, which aids in the downstream processing of DNA fragments. The second patent, "Methods and transposon nucleic acids for generating a DNA library," presents an engineered cleavage site in the transposon end sequence, facilitating the handling of DNA fragments for sequencing templates. Both patents highlight her expertise in molecular biology and genomic technologies.
Career Highlights
Laura-Leena Kiiskinen has built her career at respected organizations in the scientific community, including Thermo Fisher Scientific Oy and Thermo Fisher Scientific Baltics UAB. Her experience at these companies has provided her with a robust platform to develop her innovative ideas and patents in genetic sequencing.
Collaborations
Throughout her career, Laura-Leena has collaborated with esteemed colleagues such as Ian Kavanagh and Heli Haakana. These partnerships have fostered a dynamic exchange of ideas and expertise, further enriching the innovation landscape in which she operates.
Conclusion
Laura-Leena Kiiskinen exemplifies the spirit of innovation in the field of genetic research. Her patents not only contribute to scientific advancement but also pave the way for new methodologies in DNA sequencing. As a leading inventor, she continues to inspire future innovations in genetics and biotechnology.